全球眼部藥物傳輸技術市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

全球眼部給藥技術市場需求預計將從 2022 年的 182.1 億美元增至 2030 年的近 428.5 億美元，2023-2030 年研究期間複合CAGR為 11.29%。

眼部給藥技術是指設計用於向眼睛給藥的專門技術和系統。這些技術旨在有效地將治療劑（例如藥物或治療方法）遞送到特定的眼部組織和結構，以治療各種眼部病症和疾病。

市場動態

由於多種促進因素​​，眼部藥物傳輸技術市場正在經歷成長。首先，包括青光眼、黃斑部病變和糖尿病視網膜病變在內的眼部疾病的盛行率不斷增加，刺激了對眼部治療的先進藥物傳遞系統的需求。技術創新發揮重要作用，奈米技術、植入物、緩釋製劑和標靶遞送系統的不斷進步提高了眼部治療的藥物療效和精確度。這些創新吸引投資並推動市場擴張。針對特定眼組織的標靶和受控藥物傳輸需求也推動了市場成長，提供更有效的治療選擇，同時最大限度地減少全身副作用。此外，老年人口對眼部疾病的易感性導致對眼部藥物輸送系統的需求增加。不斷增加的研發投資、患者對非侵入性治療的偏好以及促進創新醫療技術的政府支持政策進一步刺激了市場。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球眼部藥物傳輸技術市場的各個細分市場進行了包容性評估。眼部藥物輸送技術產業的成長和趨勢為本研究提供了整體方法。

區域分析

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲眼部給藥技術市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。眼部藥物傳輸技術市場的主要參與者包括Allergan Plc.、Bausch Health Company (Valeant Pharmaceuticals International).、Santen Pharmaceutical Co. Ltd.、Alimera Sciences Inc.、Ocular Therapeutix Inc.、Envisia Therapeutics Inc.、EyeGate Pharma Inc . .、諾華公司、強生視力保健公司和輝瑞公司。本部分包含競爭格局的整體視圖，其中包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：眼部給藥技術 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按技術分類的市場吸引力分析
  • 按疾病類型分類的市場吸引力分析
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球眼部藥物傳輸技術市場分析：依技術分類

• 依技術概述
• 歷史和預測數據
• 依技術分析
• 專題
• 離子電滲透療法
• 眼插入物
• 眼內植入物
• 原位凝膠和淚點塞
• 其他

第 6 章：全球眼部藥物傳輸技術市場分析：依疾病類型

• 依疾病類型概述
• 歷史和預測數據
• 依疾病類型分析
• 青光眼
• 糖尿病性視網膜病變
• 乾眼症
• 黃斑部病變
• 白內障
• 糖尿病黃斑水腫
• 其他

第 7 章：全球眼部藥物傳輸技術市場分析：依最終使用者分類

• 最終用戶概述
• 歷史和預測數據
• 最終用戶分析
• 醫院
• 眼科診所
• 門診手術中心
• 家庭護理設置

第 8 章：全球眼部藥物傳輸技術市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：眼部給藥技術公司的競爭格局

• 眼部給藥技術市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 公司股份分析
• 市場集中度
• Allergan Plc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Bausch Health Company (Valeant Pharmaceuticals International).
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Santen Pharmaceutical Co. Ltd.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Alimera Sciences Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Ocular Therapeutix Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Envisia Therapeutics Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• EyeGate Pharma Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Novartis AG.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Johnson & Johnson Vision Care Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Pfizer Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for Ocular Drug Delivery Technology Market is presumed to reach the market size of nearly USD 42.85 BN by 2030 from USD 18.21 BN in 2022 with a CAGR of 11.29% under the study period 2023 - 2030.

Ocular drug delivery technology refers to specialized techniques and systems designed to administer medications to the eye. These technologies aim to effectively deliver therapeutic agents, such as drugs or treatments, to specific ocular tissues and structures for the treatment of various eye conditions and diseases.

MARKET DYNAMICS

The ocular drug delivery technology market is experiencing growth due to several driving factors. Primarily, the increasing prevalence of eye diseases, including glaucoma, macular degeneration, and diabetic retinopathy, fuels the demand for advanced drug delivery systems tailored for ocular treatments. Technological innovations play a significant role, with ongoing advancements in nanotechnology, implants, sustained-release formulations, and targeted delivery systems enhancing drug efficacy and precision in ocular treatments. These innovations attract investments and drive market expansion. The targeted and controlled drug delivery demand for specific eye tissues also propels market growth, offering more effective treatment options while minimizing systemic side effects. Additionally, the aging population's susceptibility to eye disorders contributes to increased demand for ocular drug delivery systems. Rising research and development investments, patient preference for non-invasive treatments, and supportive government policies promoting innovative healthcare technologies further stimulate the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ocular drug delivery technology. The growth and trends of ocular drug delivery technology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the ocular drug delivery technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

• Topical
• Iontophoresis
• Ocular Insert
• Intraocular Implants
• In Situ Gel & Punctal Plugs
• Others

By Disease Type

• Glaucoma
• Diabetic Retinopathy
• Dry Eye Syndrome
• Macular Degeneration
• Cataract
• Diabetic Macular Edema
• Others

By End Users

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers
• Homecare Settings

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Ocular Drug Delivery Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Ocular Drug Delivery Technology market include Allergan Plc., Bausch Health Company (Valeant Pharmaceuticals International)., Santen Pharmaceutical Co. Ltd., Alimera Sciences Inc., Ocular Therapeutix Inc., Envisia Therapeutics Inc., EyeGate Pharma Inc., Novartis AG., Johnson & Johnson Vision Care Inc., and Pfizer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . OCULAR DRUG DELIVERY TECHNOLOGY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Technology
  • 3.7.2 Market Attractiveness Analysis By Disease Type
  • 3.7.3 Market Attractiveness Analysis By End Users
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY TECHNOLOGY

• 5.1 Overview by Technology
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Technology
• 5.4 Topical Historic and Forecast Sales by Regions
• 5.5 Iontophoresis Historic and Forecast Sales by Regions
• 5.6 Ocular Insert Historic and Forecast Sales by Regions
• 5.7 Intraocular Implants Historic and Forecast Sales by Regions
• 5.8 In Situ Gel & Punctal Plugs Historic and Forecast Sales by Regions
• 5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY DISEASE TYPE

• 6.1 Overview by Disease Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Disease Type
• 6.4 Glaucoma Historic and Forecast Sales by Regions
• 6.5 Diabetic Retinopathy Historic and Forecast Sales by Regions
• 6.6 Dry Eye Syndrome Historic and Forecast Sales by Regions
• 6.7 Macular Degeneration Historic and Forecast Sales by Regions
• 6.8 Cataract Historic and Forecast Sales by Regions
• 6.9 Diabetic Macular Edema Historic and Forecast Sales by Regions
• 6.10. Others Historic and Forecast Sales by Regions

7 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY END USERS

• 7.1 Overview by End Users
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End Users
• 7.4 Hospitals Historic and Forecast Sales by Regions
• 7.5 Ophthalmic Clinics Historic and Forecast Sales by Regions
• 7.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
• 7.7 Homecare Settings Historic and Forecast Sales by Regions

8 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE OCULAR DRUG DELIVERY TECHNOLOGY COMPANIES

• 9.1. Ocular Drug Delivery Technology Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF OCULAR DRUG DELIVERY TECHNOLOGY INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Allergan Plc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Bausch Health Company (Valeant Pharmaceuticals International).
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Santen Pharmaceutical Co. Ltd.
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Alimera Sciences Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Ocular Therapeutix Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Envisia Therapeutics Inc.
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. EyeGate Pharma Inc.
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Novartis AG.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Johnson & Johnson Vision Care Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Pfizer Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Technology (USD MN)
• Topical Market Sales by Geography (USD MN)
• Iontophoresis Market Sales by Geography (USD MN)
• Ocular Insert Market Sales by Geography (USD MN)
• Intraocular Implants Market Sales by Geography (USD MN)
• In Situ Gel & Punctal Plugs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Disease Type (USD MN)
• Glaucoma Market Sales by Geography (USD MN)
• Diabetic Retinopathy Market Sales by Geography (USD MN)
• Dry Eye Syndrome Market Sales by Geography (USD MN)
• Macular Degeneration Market Sales by Geography (USD MN)
• Cataract Market Sales by Geography (USD MN)
• Diabetic Macular Edema Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End Users (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Ophthalmic Clinics Market Sales by Geography (USD MN)
• Ambulatory Surgical Centers Market Sales by Geography (USD MN)
• Homecare Settings Market Sales by Geography (USD MN)
• Global Ocular Drug Delivery Technology Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Ocular Drug Delivery Technology Report
• Market Research Process
• Market Research Methodology
• Global Ocular Drug Delivery Technology Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Disease Type
• Market Attractiveness Analysis by End Users
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Technology (USD MN)
• Topical Market Sales by Geography (USD MN)
• Iontophoresis Market Sales by Geography (USD MN)
• Ocular Insert Market Sales by Geography (USD MN)
• Intraocular Implants Market Sales by Geography (USD MN)
• In Situ Gel & Punctal Plugs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Disease Type (USD MN)
• Glaucoma Market Sales by Geography (USD MN)
• Diabetic Retinopathy Market Sales by Geography (USD MN)
• Dry Eye Syndrome Market Sales by Geography (USD MN)
• Macular Degeneration Market Sales by Geography (USD MN)
• Cataract Market Sales by Geography (USD MN)
• Diabetic Macular Edema Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End Users (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Ophthalmic Clinics Market Sales by Geography (USD MN)
• Ambulatory Surgical Centers Market Sales by Geography (USD MN)
• Homecare Settings Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.